We are live on ! Find out more
WMSA

Weiss Multi-Strategy Advisers Portfolio holdings

AUM $4.16B
1-Year Est. Return 30.77%
This Fund
S&P 500
This Quarter Est. Return
+5.31%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$4.18B
AUM Growth
+$1.02B
Cap. Flow
+$924M
Cap. Flow %
22.11%
Top 10 Hldgs %
22.47%
Holding
739
New
224
Increased
156
Reduced
141
Closed
206

Sector Composition

Rank Sector Weight
1 Real Estate 17.19%
2 Technology 7.54%
3 Industrials 7.53%
4 Consumer Discretionary 7.07%
5 Consumer Staples 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRAY
501
DELISTED
ViewRay, Inc.
VRAY
$379K 0.01%
54,823
-5,177
-9% -$37.6K
EPZM
502
DELISTED
Epizyme, Inc
EPZM
$370K 0.01%
27,341
+12,341
+82% +$192K
BG icon
503
PUT
Bunge Global
BG
$23.6B
$349K 0.01%
+5,000
New +$358K
TGNA
504
DELISTED
TEGNA Inc
TGNA
$349K 0.01%
32,200
-117,800
-79% -$1.28M
STAY
505
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
$346K 0.01%
15,988
-159,012
-91% -$3.26M
KPTI icon
506
Karyopharm Therapeutics
KPTI
$168M
$340K 0.01%
+1,333
New +$330K
ALDX icon
507
Aldeyra Therapeutics
ALDX
$91.7M
$320K 0.01%
40,200
-7,200
-15% -$57.4K
BPMC
508
DELISTED
Blueprint Medicines
BPMC
$317K 0.01%
+5,000
New +$398K
INSY
509
DELISTED
Insys Therapeutics, Inc.
INSY
$317K 0.01%
43,830
+7,130
+19% +$49.7K
BHVN
510
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$316K 0.01%
+8,000
New +$254K
OBSV
511
DELISTED
ObsEva SA Ordinary Shares
OBSV
$303K 0.01%
20,000
EA icon
512
Electronic Arts
EA
$52.4B
$282K 0.01%
+2,000
New +$260K
KERX
513
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$255K 0.01%
67,929
+5,929
+10% +$28.9K
AXDX
514
DELISTED
Accelerate Diagnostics
AXDX
$245K 0.01%
+1,100
New +$246K
IFRX icon
515
InflaRx
IFRX
$256M
$245K 0.01%
7,600
+600
+9% +$20.7K
UAL icon
516
United Airlines
UAL
$38.4B
$230K 0.01%
3,300
-5,628
-63% -$391K
ANW
517
CALL
DELISTED
Aegean Marine Petroleum Network
ANW
$230K 0.01%
+347,000
New +$768K
CTMX icon
518
CytomX Therapeutics
CTMX
$705M
$229K 0.01%
+10,000
New +$255K
BKS
519
DELISTED
Barnes & Noble
BKS
$222K 0.01%
35,000
-65,000
-65% -$367K
QTTB icon
520
Q32 Bio
QTTB
$450M
$204K ﹤0.01%
556
-1,666
-75% -$596K
ACH
521
Accendra Health
ACH
$240M
$184K ﹤0.01%
10,993
+993
+10% +$16.1K
METC icon
522
Ramaco Resources Class A
METC
$676M
$176K ﹤0.01%
26,177
-103,022
-80% -$734K
PACB icon
523
Pacific Biosciences
PACB
$422M
$175K ﹤0.01%
49,326
+4,326
+10% +$12K
CYTK icon
524
Cytokinetics
CYTK
$11B
$166K ﹤0.01%
20,000
-15,000
-43% -$125K
AKBA icon
525
Akebia Therapeutics
AKBA
$327M
$142K ﹤0.01%
14,234
+1,234
+9% +$12.4K

Similar funds

Weiss Multi-Strategy Advisers's Q2 2018 Portfolio in Review

As of Q2 2018, Weiss Multi-Strategy Advisers held 739 positions worth $4.18B, up 32% from $3.16B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Weiss Multi-Strategy Advisers deployed $924M of net new capital in Q2 2018, opening 224 new positions and adding to 156 existing holdings. Its largest new stake was American Homes 4 Rent: 3,000,000 shares worth $66.5M.

By sector, the portfolio is most concentrated in Real Estate at 17% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Canadian National Railway, an estimated $30.8M trimmed.

  • Weiss Multi-Strategy Advisers's largest Q2 2018 buy was American Homes 4 Rent: 3,000,000 shares worth $66.5M.
  • Weiss Multi-Strategy Advisers added most to Equity Lifestyle Properties in Q2 2018, an estimated $45.5M increase.
  • Weiss Multi-Strategy Advisers's biggest Q2 2018 reduction was Canadian National Railway, cutting an estimated $30.8M.
  • Weiss Multi-Strategy Advisers fully exited American Campus Communities, Inc. in Q2 2018, selling an estimated $33.4M.
  • Weiss Multi-Strategy Advisers's ten largest holdings make up 22% of its $4.18B portfolio in Q2 2018.
  • Weiss Multi-Strategy Advisers opened 224 new positions and closed 206 in Q2 2018.
  • Weiss Multi-Strategy Advisers's portfolio value rose 32% quarter-over-quarter to $4.18B.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2018, filed 14 Aug 2018.